Stellartech Research

Stellartech Research is a privately held, established medical device CDMO with deep expertise in energy-based therapeutic systems, combining disposable patient-contact devices with microprocessor-controlled instruments. Founded in 1986 and headquartered in Milpitas, California, the company offers end-to-end services from R&D to ISO 13485:2016 compliant manufacturing in its 68,000 sq. ft. facility. Its business model is service-based, providing outsourced development and manufacturing solutions primarily for Class II and Class III medical devices across various therapeutic areas, positioning it as a key partner in the medtech innovation ecosystem.

Integrated service platform for medical device development, with distinctive expertise in RF, ultrasound, and therapeutic energy delivery systems combining capital instruments with disposable patient-contact devices. Capabilities span electrical/electronics, software, patient-contact device, and industrial design engineering.

Stellartech competes in the fragmented medical device CDMO market against other specialized engineering firms and larger contract manufacturers. Its primary competitive advantages are its long-standing focus on complex energy-based systems, integrated 'concept-to-commercialization' services, and its niche expertise in supporting Class III device development and manufacturing.